Robb Gary Charles

Avg. Two Year Performance

29% Avg. Purchase Return
14% Compound
(3%) Avg. Sale Return
(1%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return23%37%102%79%29%
Purchase Success Rate1 of 11 of 11 of 11 of 11 of 1
Average Sale Return3%4%3%(3%)(3%)
Sale Success Rate2 of 62 of 61 of 61 of 60 of 6
Drugs » Biotechnology

Chief Business Officer:

Holdings: 32.44K shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--